At ESMO 2014, Prof Charles Swanton (London Research Institute and UCL, London, UK) discusses how understanding the genetic changes in tumour evolution may contribute to the development of more effective management options that are tailored to individual genetic profiles – this is termed ‘precision medicine’.
Login to continue
Members
Create Account
Create your own personal healthcare feed, full of the latest content from across our divisions.
Register
![EMJ Oncology 10 [Supplement 6] 2022 Feature Image](https://emj.emg-health.com/wp-content/uploads/sites/2/2022/03/EMJ-Oncology-10-Supplement-6-2022-Feature-Image-940x563.jpg)
![EMJ Oncology 10 [Supplement 5] 2022 Feature Image](https://emj.emg-health.com/wp-content/uploads/sites/2/2022/03/EMJ-Oncology-10-Supplement-5-2022-Feature-Image-1-940x563.jpg)